Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ranawaka, G. R. R.
Fleck, S. L.
Alejo Blanco, A. R.
and
Sinden, R. E.
1994.
Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiationin vivo.
Parasitology,
Vol. 109,
Issue. 4,
p.
403.
MARGOS, GABRIELE
KURTENBACH, KLAUS
POSNETT, ELSA
BARKER, GUY C.
MATSUOKA, HIROYUKI
PATON, MICHAEL G.
and
SINDEN, ROBERT E.
1995.
Expression of the Plasmodium berghei ookinete protein Pbs21 in a baculovirus‐insect cell system produces an efficient transmission blocking immunogen.
Parasite Immunology,
Vol. 17,
Issue. 4,
p.
167.
Sinden, R.E.
Butcher, G.A.
Billker, O.
and
Fleck, S.L.
1996.
Advances in Parasitology Volume 38.
Vol. 38,
Issue. ,
p.
53.
Sinden, R. E.
1997.
Antimalarial transmission-blocking vaccines.
Annals of Tropical Medicine & Parasitology,
Vol. 91,
Issue. sup1,
p.
S69.
Tsuboi, T
Cao, Y M
Hitsumoto, Y
Yanagi, T
Kanbara, H
and
Torii, M
1997.
Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity.
Infection and Immunity,
Vol. 65,
Issue. 6,
p.
2260.
Healer, J
McGuinness, D
Hopcroft, P
Haley, S
Carter, R
and
Riley, E
1997.
Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.
Infection and Immunity,
Vol. 65,
Issue. 8,
p.
3017.
Martínez, Andrés Páez
Margos, Gabriele
Barker, Guy
and
Sinden, Robert E.
2000.
The roles of the glycosylphosphatidylinositol anchor on the production and immunogenicity of recombinant ookinete surface antigen Pbs21 of Plasmodium berghei when prepared in a baculovirus expression system.
Parasite Immunology,
Vol. 22,
Issue. 10,
p.
493.
Shahabuddin, Mohammed
and
Costero, Adriana
2001.
Spatial distribution of factors that determine sporogonic development of malaria parasites in mosquitoes.
Insect Biochemistry and Molecular Biology,
Vol. 31,
Issue. 3,
p.
231.
Sinden, R. E.
2002.
Molecular interactions betweenPlasmodiumand its insect vectors.
Cellular Microbiology,
Vol. 4,
Issue. 11,
p.
713.
Drakeley, C. J.
Eling, W.
Teelen, K.
Bousema, J. T.
Sauerwein, R.
Greenwood, B. M.
and
Targett, G. A. T.
2004.
Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children.
Parasite Immunology,
Vol. 26,
Issue. 4,
p.
159.
Abraham, Eappen G
and
Jacobs-Lorena, Marcelo
2004.
Mosquito midgut barriers to malaria parasite development.
Insect Biochemistry and Molecular Biology,
Vol. 34,
Issue. 7,
p.
667.
Reece, Sarah E
Duncan, Alison B
West, Stuart A
and
Read, Andrew F
2005.
Host cell preference and variable transmission strategies in malaria parasites.
Proceedings of the Royal Society B: Biological Sciences,
Vol. 272,
Issue. 1562,
p.
511.
Baton, Luke A
and
Ranford-Cartwright, Lisa C
2005.
Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells?.
Malaria Journal,
Vol. 4,
Issue. 1,
Vinetz, J. M.
2005.
Malaria: Drugs, Disease and Post-genomic Biology.
Vol. 295,
Issue. ,
p.
357.
Nikolaeva, Daria
Draper, Simon J
and
Biswas, Sumi
2015.
Toward the development of effective transmission-blocking vaccines for malaria.
Expert Review of Vaccines,
Vol. 14,
Issue. 5,
p.
653.
STONE, WILL J. R.
DANTZLER, KATHLEEN W.
NILSSON, SANDRA K.
DRAKELEY, CHRIS J.
MARTI, MATTHIAS
BOUSEMA, TEUN
and
RIJPMA, SANNA R.
2016.
Naturally acquired immunity to sexual stageP. falciparumparasites.
Parasitology,
Vol. 143,
Issue. 2,
p.
187.
Sinden, R. E.
Biswas, Sumi
and
Blagborough, A. M.
2017.
Malaria.
p.
241.
Sinden, R.E.
2017.
Vol. 97,
Issue. ,
p.
147.
Bousema, Teun
and
Drakeley, Chris
2017.
Determinants of Malaria Transmission at the Population Level.
Cold Spring Harbor Perspectives in Medicine,
Vol. 7,
Issue. 12,
p.
a025510.
Tachibana, Mayumi
Ishino, Tomoko
Tsuboi, Takafumi
and
Torii, Motomi
2018.
The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
Vaccine,
Vol. 36,
Issue. 49,
p.
7463.